It started, as with many modern love stories, with a swipe.
In 2015, Paul van Donkelaar, a recently divorced neuroscience professor, met Karen Mason, a woman working with survivors of intimate partner violence.
They started dating and fell in love. To begin with, they were just another couple who happened to have found their happily ever after through online dating. But it soon became clear that there were bigger forces at play.
“We’re definitely unique,” says Karen, who is executive director of Kelowna Women’s Shelter in British Columbia, Canada.
“The fact that the universe decided to put Paul and I together, when I am the executive director of an organisation that provides shelter to women fleeing violence, and he’s a neuroscientist with an expertise in concussion. There’s clearly some universal plan afoot.”
Not long after they began dating she came across an article highlighting an epidemic of traumatic brain injury (TBI) among survivors of intimate partner violence (IPV).
As a professor of neuroscience at the University of British Columbia in Canada, Paul has been researching brain injury in the context of sports concussion for more than 20 years.
But while much has been done to explore the impact of head injuries on athletes, the studies on IPV are still relatively scarce. He started to question why more work wasn’t being done.
“I didn’t have a good answer,” he admits.
One in three women, and one in four men, will experience some form of IPV in their lifetime, according to the US-based National Coalition Against Domestic Violence (NCADV).
In Canada, statistics show that 207,000 women will experience a severe violent episode at the hands of a partner each year.
Of those women who seek help, either from medical professionals, A&E departments or women’s shelters, as many as 90 per cent report symptoms consistent with concussion.
“For every man who suffers a concussion playing the sport they love, 7,000 women suffer the same injury at the hands of the man they love,” Karen announced in her and Paul’s 2017 TEDxTalk ‘Ahead of the Game’.
“I realised that this was something that was probably going on with most of our clients and I insisted that we needed to do something about it,” she says now.
“We know that most physical violence within relationships is based on blows to the head and neck and there’s also the strangulation aspect.
“Most women experience physical blows to the face, head and neck, and strangulation, so brain injury is a natural implication of that.
“The stories we hear are extreme. One woman has spoken about the number of times she was thrown out of a moving car, and the occasions on which he repeatedly smashed her head against the floor.
“It is distressingly common.”
With their individual expertise, Karen and Paul were well placed to make a real difference to these women. In 2016, they launched their project Supporting Survivors of Abuse and Brain Injury through Research (SOAR) – a collaboration between the University of British Columbia and Kelowna Women’s Shelter.
In June 2019, they received a US$1m grant from the Canadian government’s department for Women and Gender Equality, to continue the research for another five years.
The study takes several approaches, both scientific and community-based, to improve the quality of life for survivors of IPV.
“We’re in a position to create some promising practices that may change the way that women’s shelters interact with their clients, the referral network and the way healthcare systems and community-based supporters accommodate and support women who have experienced IPV,” says Paul.
The fact that the government has supported the project so substantially is noteworthy in itself, and shows a recognition and understanding of the desperate need for this research.
“It’s groundbreaking. It’s very important to have direct funding supporting research around this topic, because it could have a huge impact on the quality of life of participants themselves, and in the way practices are done,” Paul adds.
“The goal of this specific funding is to create a blueprint that can be used across Canada, both within the healthcare system, and within community organisations that support women of IPV.
“That’s our ultimate goal.”
Recruiting participants from the Kelowna Women’s Shelter, Paul and his team are measuring physiological changes such as blood flow, to better understand the characteristics of brain injury in survivors.
They are also carrying out assessments for psychological comorbidities such as posttraumatic stress disorder (PTSD), anxiety and substance abuse.
He is using assessments which have proved to be successful over many years of studying concussion in athletes.
Sports related concussions and the link between contact sports and CTE are a growing concern for athletes.
The Centre for Disease Control (CDC) now estimates up to 3.8 million sports related concussions occur every year in the US and more than 100 NFL players have been diagnosed with CTE at the VA-BU-CLF Brain Bank in Boston.
While studying the effect of repetitive impacts to the head in contact and non-contact sports, Paul’s research was among the first to show that certain markers of nerve cell injury were elevated following multiple hits, and that these could be linked to a higher number of concussion-like symptoms such as headaches, dizziness and confusion.
Concussions sustained through IPV, however, are more complex to dissect.
“It’s clear that people who have experienced IPV are very likely to have a brain injury as a result of that, but it’s not like in a sports concussion situation where it happens at a sporting event, there are lots of witnesses and you can very quickly do an assessment and determine that a concussion has taken place,” says Paul.
“In the IPV population quite often it’s months to years before they seek help and so the injuries tend to be remote in time and tend to interact with some of the comorbidities.
“It’s really important to disentangle all of those factors and get a good sense of how much of the challenges they are currently facing are due to the head impacts they have received as a result of their experience.”
The information will then be used to develop tools and training resources for frontline staff and services who come directly into contact with survivors of IPV, to help them provide more effective support.
Frontline workers will also be trained in how to spot the signs and symptoms that someone is suffering from a brain injury, to help them flag up vulnerable women.
Women who may come across as “difficult”, suffer from behavioural issues, memory loss, or struggle to complete basic tasks that would allow them to move forward into a life free from abuse, are actually most likely displaying symptoms of an undiagnosed brain injury.
“For gender-based violence research, this is so critical as it is not something that we have ever taken into account before,” says Karen.
“For those of us who work in the industry, it’s going to play a huge role in creating new support systems when we’re trying to help women be healthy and better.
“If you’re coming to this without any previous knowledge that perhaps there are other factors at play such as a brain injury, your level of empathy and patience, and ability to support that woman is severely diminished.
“We should be approaching every woman we serve based on an understanding that she probably has suffered at least one, if not more, brain injuries.”
This could be as simple as making small adjustments such as interviewing a client in a calming, dimly lit, environment away from other activity, as opposed to a brightly lit, noisy room.
“A simple step like that is very specifically directed at supporting someone who has a brain injury, and is something that frontline workers and shelters could be doing right now,” says Karen.
Their long-term goal is to create a community-based support referral network, bringing various support systems together, from medical care to occupational therapy and speech pathology, so that survivors who may have sustained a brain injury have access to a wealth of support on hand.
Paul is also developing a Concussion Awareness Training Tool (CATT), a web-based utility, originally designed for use in sports concussion.
It has proved hugely successful for educating and increasing awareness of concussion and TBI in the sports industry, and it is hoped it can do the same for those working with survivors of IPV.
“The idea is to create a new module of the CATT online, specifically for those working in the IPV sector, with the goal of increasing awareness of TBI in the population and then disseminating that as widely as possible,” he says.
“We hope to have that up and running and in place by next year.”
In the meantime, SOAR is already beginning to see results on the ground, with Kelowna Women’s Shelter leading the way.
“It’s the thing that is in mind for staff whenever they do an intake with a new client, or whenever they are dealing with a particularly challenging client,” says Karen.
“Five years ago that wasn’t the case, so we’re definitely seeing change.
“I know other shelters are now thinking about brain injury and I’ve had executive directors from other shelters tell me that it has changed the way they approach their clients.”
But it’s the survivors of IPV themselves who have seen most of the impact.
The fact that someone wants to listen and acknowledge their experience has given them a sense of empowerment.
“For women experiencing IPV this is their normal,” Karen explains.
“It might be normal to wake up and be dizzy because of the physical fight they had with their partner last night, or forget things all the time and he tells her she is just stupid.
“She internalises all those messages and it might never cross her mind that she actually has a physical condition that is a direct result of how her partner treats her.
“We’ve had women go through this process and almost have a sense of empowerment at the end, because they feel like they have a label for this, that it’s not their fault, and maybe there are things that can be done to help them.”
And ultimately, that is what the project is all about.
“The reality is, women make up more than half the population, and at least a third of them, statistically, will be in this situation.
“Many, if not most of them, will see some sort of impact to the head and possibly a brain injury,” says Karen.
“Brain injury can be a hidden injury and IPV is also often an invisible problem.
“In 2019, we’re still dealing with some of that shame and stigma, it’s still an issue that many people prefer to pretend doesn’t happen.”
Paul and Karen are not those people.
They are committed to increasing research into the impact of concussion beyond what might be seen in athletes, says Paul: “We know helping them achieve a healthy life, free from abuse, is good for all of us.”
It’s a good job then, that they both swiped right.
SameYou – a catalyst for change
Tackling the vital issues of the lack of neurorehabilitation provision and the ongoing stigma around brain injury, SameYou was founded by globally-famous actor Emilia Clarke to fight the corner and provide a voice for survivors who feel they are forgotten. NR Times speaks with Emilia’s mum Jenny Clarke, CEO of SameYou, about the charity’s brave campaigning and funding of research which is making waves on a global scale
As the CEO of a charity committed to making a difference to the lives of people living with brain injury, as well as being the mother of a survivor, and a patient herself, Jenny Clarke truly understands the impact of acquired brain injury.
In a twist of fate, like her daughter Emilia, Jenny also has two mirror aneurysms in her brain. While Emilia almost died twice, mercifully Jenny did not experience such traumatic illness – yet its impact it still life-changing.
“It’s familial, apparently. It was a complete fluke that I found out, really,” says Jenny.
“I went for an MRI scan, and they said, ‘You’re fine, but did you know you have two aneurysms?’ It was a shock.
“So I do understand what it’s like to have that diagnosis, especially after what happened to Emilia.”
Emilia’s story is, of course, now well documented. Globally-famous Emilia, best known as Daenerys Targaryen from Game of Thrones, had the first of two brain haemorrhages in 2011, just after she had finished filming season one of the iconic series.
The Emmy-nominated actor and her family continue to be indebted to the National Hospital for Neurology and Neuroscience (NHNN) Queen Square in London, which they credit with saving Emilia’s life.
Emilia has since become an ambassador for the Royal College of Nursing and Nursing Now, after the hugely positive impact of nursing care during her time in Queen Square; indeed, her relationship with her nurse at NHNN continues to this day.
Her second haemorrhage, in a hospital in New York two years later, was caused when a preventative procedure failed.
Six years later, in 2019, having been shocked at the lack of focus on brain injury and its seismic impact – and the stigma that continues to persist in speaking out, despite the fact one in three people sustain brain injury during their lives – Emilia took the brave decision to share her story for the first time, to help inspire others who sustain brain injury and are forced to live with its effects.
“We realised we had to do something because she has a global platform. It took a long time to tell her story, it is very, very difficult to talk about. There is stigma and shame attached to it, people don’t know what to say, there is no common language,” says Jenny.
“Shockingly, brain injury is the biggest problem in the neurological world, it’s bigger than dementia – but who is saying anything about it?
“Emilia had no idea (anything was wrong) before her first aneurysm, we had no history of stroke in the family, there was no warning. She was going through this tremendous transition with Game of Thrones when she nearly lost her life.
“Then two years later, she came even closer to losing her life when her preventative treatment for her aneurysm went wrong, which I think highlighted how fragile the brain is. But she was lucky, being young and very fit, she survived, and has learnt to manage her residual fatigue, but our family knows how hard it is to cope with the impact of a sudden brain injury.
“This whole experience made us realise how very different things could have been.”
Committed to changing the situation, Emilia established SameYou, a UK and USA registered charity which tackles the issue of the lack of neurorehabilitation and stressing the need for holistic and ongoing care and support once an ABI survivor leaves hospital.
Building on Emilia’s profile and personal experience, alongside Jenny’s expertise in business, the charity is already making waves around the world. With a website – sameyou.org – bustling with signposting information through its UK Neuro Recovery Directory, advice from leading experts and inspirational video content, survivors can find a host of resources on a daily basis, while knowing SameYou is fighting hard on their behalf in the background to bring about change.
SameYou is also collaborating with global partners to find and test new treatments, with a number of exciting projects already underway.
“With brain injury, you’re the same person inside even if your brain doesn’t let you appear that way. But you’re the same you,” says Jenny.
“We decided the biggest gap we could see was in rehabilitation, there is next to nothing. If you’re severely injured, or have a TBI or stroke, then you can get up to 12 weeks of rehabilitation in the UK it’s similar in the States, but resources are so scarce.
“The accessibility of neurorehabilitation at the moment is completely inequitable. If you’re lucky enough to be referred to Queen Square, then lucky enough to get in, then you have access to this fantastic care – but when you have a brain injury, it does alter the way you live your life. Often, people have no hope and thousands of survivors tell us they feel abandoned.
“We want to put all our energy into this to make sure people get access to the resources and support that will help them recover.”
The scale of the task ahead is something Jenny and the SameYou team continue to be shocked by but determined to make a positive difference – “We are certainly punching above our weight as a small startup, but believe that partnerships to deliver change will make the most impact on survivors and their families,” says Jenny.
“The only positive thing I can say about COVID is this new consciousness is that people are realising hat recovery care is essential. Everyone understands the need for research, and the fantastic advances in acute care, but recovery is not prioritised,” says Jenny.
“Successive Governments around the world have ignored it, social services can’t provide it. We want to make as loud a noise as possible to represent the voices of brain injury and stroke survivors and their carers.
“When I was a child, my grandmother and aunt had cancer and that was almost shameful – but look at how we regard cancer now. It shows the great strides we have made in that area, and I see that we are at the start of making that change with brain injury.
“I do feel that there are so many people who want to make a difference – and who are doing great work, but our impact is reduced without collaboration.”
And through such collaboration, SameYou is already making its mark.
One area it is particularly passionate about is nursing care and in partnership with the RCN Foundation and the University of Edinburgh has developed the landmark Advanced Practice Neurological Rehabilitation Education Programme, to enable better care for young people recovering from brain injury and stroke.
“When the brilliant neurosurgeons have saved your life, you don’t get to see them often and the continuity of care is delivered by nurses. If you have a specialist nurse who combines her clinical experience with care and compassionate that makes all the difference,” says Jenny.
“Nurses can give confidence, strength and reassurance.
“We still keep in touch with Tina, Emilia’s nurse at Queen Square. If Emilia is in LA, she will phone with any questions she has and get those answers from Tina, which shows the level of bonding and trust.
“Through our work, we want to help create holistic rehabilitation, which we describe as being for ‘brain, body and mind’. We aren’t ashamed about using non clinical language because that’s how survivors think about it.
“Every person with brain injury wants to be treated as a whole person so motor, cognitive and emotional support is essential for the best possible recovery.”
Another initiative is to support and popularise the use of telerehabilitation for brain injury, through its work with N-ROL. Having initially been piloted at UCL, N-ROL aims to reduce social isolation and improve self-efficacy for ongoing post-stroke recovery by providing high quality, group-based online neurorehabilitation to patients denied conventional therapy due to COVID-19.
It is now being rolled out into East Lancashire Hospitals NHS Trust, working alongside the University of Central Lancashire.
“Technology is so important, and telerehabilitation has to be an essential part of the recovery pathway,” says Jenny. SameYou is partnering with Visionable, a pioneering healthcare techniology company who are using their advances to improve the stroke and brain injury pathways.
“We believe strongly that telerehabilitation gives rehabilitation people would not get otherwise. Hospitals can only see a limited number of patients a year, outpatient rehab numbers are so limited, so we see the role telerehabilitation can play.
“Like with UCL, East Lancashire are committed to neurorehabilitation. We funded a pilot there and are trying to find the money to broaden that to other Trusts in their area.”
While the pandemic has delayed one of its most eagerly awaited initiatives, the three-year project with Spaulding Hospital in the United States – which explores the interplay between physical, mental and social challenges of brain injury survivors – happily it is now set to get underway.
“We recruited the cohort and then COVID came, but the project is now starting,” says Jenny.
“We are looking at young adults’ resilience after brain injury, it is biopsychosocial research. One of the lovely things is that a lot of the team are young investigators, brilliant and very qualified to understand the issues.”
With great progress already being made for the startup charity, its mission to truly make brain injury more accepted, with more resource channeled into care provision, is one that will only grow.
“We have a long way to go,” says Jenny.
“With cancer for instance, you can ‘box’ it, whether it’s in the breast or the bowel for example, but when your brain is injured there is the sense that your brain has let all of you down.
“When you have a head trauma, people often tell us they think it’s their fault, any sort of brain injury is shockingly sudden and totally unexpected so there is no time to prepare yourself.
“With endovascular coiling, which is used to treat an aneurysm, it’s a procedure which I found out uses technology that started 20 years ago. Every minute we’re getting new upgrades and updates on your phone – why not here?
“We are a catalyst for change and are convening the most innovative minds in neuroscience, technology and neurorehabilitation to collaborate and put survivors at the heart of change and make a positive change.
“That’s what we want to do – play our part in making brain injury recovery better.”
‘The day we can say this company is successful is the day we save a life’
Hailed as the future of cancer diagnostics, Dxcover is set to revolutionise healthcare by pioneering a new test to diagnose cancer more quickly, simply and cost-effectively than ever before. CEO Dr Mark Hegarty and chief technology officer Dr Matthew J Baker discuss their pioneering work to date in brain cancer detection
Through the AI-led analysis of a single drop of blood, it is possible to detect brain cancer.
Having been verified through two groundbreaking clinical studies, the Dxcover Brain Cancer liquid biopsy, the first of its kind in the world, is now set to go into pivotal trials with a view to commercialisation in 2024 – paving the way to save lives and improve quality of life globally through the earlier diagnosis of cancer.
With the creation of the Dxcover Platform – which combines novel hardware with artificial intelligence algorithms to analyse a patient’s blood – and its patented Drop Dry Detect method of detecting cancer, a process which currently may take eight weeks or more to fully diagnose can be fast-tracked into a matter of minutes.
At a time when COVID-19 has increased waiting times for cancer diagnosis and treatment dramatically, the creation of a technology which simplifies and quickens the process of diagnosis is being widely supported, with £5.1m raised to date to progress its work.
And its application is also set to be extended into other forms of cancer, with the Scottish startup currently developing liquid biopsies for individual cancers through its Dxcover Cancer project, as well as a multi-cancer test which could detect many forms of the disease.
The business, which began life as a research project at the University of Strathclyde and spun out in 2019, plans to launch its first life-saving technology initially in the United States pending the success of the pivotal trial and regulatory approval process.
Dxcover – which recently rebranded from ClinSpec Diagnostics, and now also has the tagline The Future of Cancer Diagnostics – has also expanded into laboratory and office space in Glasgow three times the size of its former base, to help facilitate its ongoing growth and further development of its pioneering work.
“We work on the basis that every day counts – for patients who need a diagnosis and treatment, for doctors looking for better diagnostic methods, for healthcare service providers who want to do things more efficiently,” says Dr Mark Hegarty, CEO of Dxcover.
“But the day we will be able to say this company is successful is the day we can say we have saved a life.”
The company’s journey towards its lifesaving aims began in 2012, when Dr Matthew J Baker began his first experiments to establish whether a biopsy could be analysed by AI to distinguish between cancer and non-cancer diagnoses.
Once the potential of his work was realised, Dr Baker – an inventor with over 18 years’ experience in the field of clinical spectroscopy – patented his spectroscopic liquid biopsy technology and was introduced to Dr Hegarty by the University, who were keen to bring in the expertise to support the development of such game-changing research into a viable business which could apply its technology around the world.
Dr Hegarty, with over 20 years of experience in supporting startups and healthcare products into international successes, immediately recognised the potential of what Dr Baker had created – and the two men also realised they could work together effectively – “We both like fast response times and are not afraid of hard work,” says Dr Hegarty.
And from there, Dxcover has progressed into a venture with the clear potential to transform cancer diagnosis as we know it, leading the way in the marketplace with its innovation.
“Liquid biopsy is a hot topic, it’s a cutting-edge technique which holds great promise,” says Dr Baker, chief technology officer of the business.
“Most research focuses on genomic data, the big US companies are focusing on the genetic information from the tumour – but ours is different and looks at the entire signal from the serum. We don’t just look at tumour markers, we look at the human response. That is then teased apart by machine learning.
“There isn’t really another company out there with our approach, and we hold the patents for the diagnosis of all cancers, so no-one can do exactly what we do. Our platform methodology can handle any serum sample, it’s exactly the same analysis, so there’s great potential.”
Supported by a hugely capable and growing senior leadership team – its most recent appointment being operations director Dr David Eustace, an experienced figure in regulated diagnostic product development – Dxcover is working to a clear plan of how to build its cancer diagnosis offering.
“The most important thing at this stage is being able to add more data. Everything depends on the quality and value of the data. The growth of our data set is the key thing,” says Dr Hegarty.
“Our Dxcover Cancer project is a multi-cancer study aimed at developing a test to detect several cancers from a single blood sample, and also to indicate the organ of origin. That would be very beneficial for clinicians are often faced with vague symptoms, making it very difficult to pin down whether a person has cancer and the type of cancer.”
While its initial target for Dxcover Brain Cancer rollout will be the United States, the company continues to be based in its native Scotland, where it has progressed so strongly, benefiting from the backing of the Scottish Enterprise High Growth programme in its earliest days, which the team credit with being crucial in its development.
“We may well add an office in Europe as we progress, and will definitely have an office in the States sooner rather than later,” says Dr Hegarty.
“We are also looking to attract a highly-experienced set of US advisors, which we believe will be key to our growth.”
Dr Baker adds: “Being based in Glasgow gives us access to great young talent coming from the universities, we haven’t had any issues in employing the next generation of spectroscopists. For me, having our R&D hub here we benefit from the health tech ecosystem in Scotland, and it fits perfectly with what we want to do.
“We have a great team and strong values and we’re all working towards the same thing – saving lives.”
Redefining rehab possibilities through gaming
With the creation of LusioMATE, rehabilitation is being revolutionised through the use of gaming. NR Times meets Justin Keenan, CEO of Lusio Rehab, to learn more about the world-first device
From a series of chance encounters came the creation of a business which is helping to revolutionise therapy and rehabilitation on a global scale through the use of gaming.
With the creation of LusioMATE, the world’s first wearable therapy controller and game ecosystem, Lusio Rehab is helping to redraw the boundaries and rehab potential for people living with neurological conditions and other disabilities around the world.
Since its launch in 2019, the device has expanded far beyond its origins in Australia to be in use in the UK, across Europe, the United States and South America.
Already widely adopted by neuro professionals to create bespoke exercise programmes for both ‘in-clinic’ and ‘at-home’ settings – with groundbreaking technology providing real-time data to monitor clients’ engagement remotely – during the pandemic, the use of LusioMATE has “skyrocketed”, and manufacturing capacity has had to be scaled up to meet this growing demand.
Another area where demand is high is for fresh gaming content. With a current suite of 28 games developed in house, Lusio Rehab’s commitment to constantly expand on the client experience, whether through new games or new feature development, is strong and something they take very seriously.
“I think the most rewarding thing for us is when we hear of the achievements that are made through using LusioMATE, when clients have gone far beyond their preconceived ideas of what they are capable of,” says Justin Keenan, CEO of Lusio Rehab.
“By being completely engrossed in their exercise via the games we have created, people are way surpassing their pre-supposed limitations. It genuinely gives me goosebumps to know we’re enabling such achievements. We talk about ‘rehab without boundaries’ and I think that’s exactly what it is.
“But while we’re delivering incredible results, this isn’t a finished product and it probably won’t ever be. Since the earliest days, we’ve been led by clients and professionals, that’s how our story started, and that will always be the case. We’re building the car as we’re driving it.”
The business has been blessed by many interventions – “we’ve had a lot of sliding door moments and serendipity”, says Justin – which have enabled it to get to where it is today.
Back in 2015, Armin Songhori, now head of tech at Lusio Rehab, was working in his native Iran. A seasoned entrepreneur and robotics engineer, he was approached by a doctor friend, who was treating Arshia, a five-year-old boy with Cerebral Palsy.
“He was struggling to find a way to engage Arshia in at-home therapy, he wasn’t motivated to do it at all,” says Justin.
“Armin got thinking, and realised a remote-controlled car may be a good place to start with a young boy. He created a bendable sensor for Arshia’s wrist, which enabled him to control the car whilst doing his therapy, and Arshia absolutely fell in love with it.
“That was the eureka moment for Armin in how gamification could help with physical therapy. That was the start of the rollercoaster ride into the world we now find ourselves in.”
Armin then moved to Australia, where Justin ran a recruitment business. Justin needed help in shortlisting candidates with expertise in C++ code, and was introduced to Armin by fellow recruitment entrepreneur Chris McGowan, who was also to become part of the Lusio Rehab story.
“While we were working together, Armin told me about his invention for Arshia, which was now onto its fourth prototype, and he asked what I thought. It was amazing – but without any experience of how to launch this type of product and no experience in healthcare, we were just three friends on a mission to see where it took us,” says Justin.
Then came the next stroke of luck.
“When meeting with an IoT expert in our network we learnt of the Cerebral Palsy Alliance and their Remarkable Tech accelerator programme, which championed technology to improve the lives of people living with a disability. It sounded perfect for us – but the deadline was that same day,” recalls Justin.
“Fortunately, we got the application in, completed the pitch, and were shortlisted onto the programme. Being mentored by leaders in medtech and working closely with clinical experts, within six months we’d gone from a great idea to the foundations of a great product that could change people’s lives.”
And from there came a business which is delivering often life-changing moments. Whether for children who struggle with habilitation, or for adults who have seemingly reached their potential, or for older people in care homes, LusioMATE is helping people to realise new possibilities.
Initially rolled out through the Cerebral Palsy Alliance network across New South Wales, its ease of use and ability to engage people of all ages and abilities through gaming has been central to its worldwide growth.
“That’s the core principle – it’s inclusive – but we are constantly working on new features,” says Justin.
“We’re continually working with clients and therapists to ensure it delivers. We’re proud that any age group, of any physical capability, who require physical therapy to prevent deterioration or improve quality of life, will benefit from LusioMATE. The sensors can be tailored to the client’s specific range of motion such that it can really help anyone, regardless of their range of movement.
“At the same time, although technology is amazing, if people don’t know how to use it, or it’s not what they need, then it’s useless. We’re certainly not afraid to revise any part of its DNA and do so all the time.
“We originally launched with a prescription gaming feature where therapists could create very detailed exercise plans. However feedback from our clinical partners taught us that they didn’t have time for duplication of work, writing their own internal client reports and prescriptions to LusioMATE. But they loved the idea of creating movement goals for their clients, so we designed ‘the detail’ out and streamlined the experience.
“We are always engaging with people, listening to their feedback and responding. We’re also lucky to have an exceptional team who work tirelessly on every aspect of the tech and client experience.
“We’re not a developer of assistive technology who creates a product then that’s it, we want to be on the journey with the people who use it.”
One area in which LusioMATE has always been hugely effective – and particularly so during the pandemic – is with its at-home rehab.
“When clients do their therapy at home, I don’t think it’s uncommon for a bit of ‘slacking off’ to happen, but for the first time ever, physios and OTs can get real time data to see whether that is the case or not, which allows them to triage the situation,” says Justin.
“As with Arshia in the very earliest days of Lusio, the need to do at-home therapy is hugely important, but often people aren’t as engaged as they could be. But through gamification, we’ve helped to address that.
“When the pandemic hit, telehealth came in pretty much overnight, and with LusioMATE, the therapy could move from being physically in-clinic to being at-home.
“Those therapists who already used LusioMATE already had the clients’ bespoke plans in place, and they could be monitored remotely using that data. And among individual users, the take-up absolutely skyrocketed for us.
“Clients soon realised that the remote limitations were endless, with the scope for taking LusioMATE on holidays, while travelling, and even when working. Essentially LusioMATE is a therapist in your pocket.”
Going forward, Justin and his team are focused on continuing the global roll-out, with LusioMATE now ahead in its strategic plans due to its huge popularity during the pandemic.
“When we first launched the product, we did worry it was too early, but like with all inventions there are the early adopters who helped it to grow, and we built from there – now, we have built really strongly during the past year and will keep going,” says Justin.
“We are bringing more clients in day by day, week by week, and are increasing our client base in both born and acquired disability and injury.
“We continue to add new features, most recently a trophy-based reward system to motivate player adherence, which also doubles up as an ‘at a glance’ monitoring tool for clinicians too.
“There is a whole range of data that we can provide to clinicians for monitoring, and we are currently looking to expand what data we can display in-app for easy reference.
“We’re also looking to create an inclusive leaderboard – one that is based on achievement of goals and not necessarily on how long or how many times you’ve played something.
“We’re constantly looking at how to make the game play a richer experience, and adapting what we do in response to client and therapist needs. The work is ongoing and we’re committed to making LusioMATE the best it can be.
“The difference we’ve made so far has been fantastic – not in terms of the market necessarily, we’re not a disruptor, but to people’s lives. To hear the stories of people who have achieved and exceeded their personal movement goals is what it’s all about. Helping people like this is such a privilege for us all at Lusio Rehab.”
Dementia3 weeks ago
The Robo pets helping dementia and Parkinson’s patients
News3 weeks ago
Scientists discover new class of memory cells in the brain
Research2 weeks ago
Largest-ever brain cancer clinical trial underway
Dementia4 weeks ago
Can you predict your own dementia risk?
Neuro physio2 weeks ago
NeuroBall™: enabling progress in rehabilitation
Brain injury2 weeks ago
TBI in UK Armed Forces to be investigated
Brain injury2 weeks ago
Watch the webinar: Understanding and managing suicidal risk
News2 weeks ago
Vocal music boosts the recovery of language functions after stroke